A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD)

The primary objective of this study was to evaluate whether OROS-MPH (Concerta), relative to placebo, increases the effectiveness of standard smoking treatment (i.e., nicotine patch and individual smoking cessation counseling) in obtaining prolonged abstinence for smokers with ADHD. The study involved 255 participants, recruited from six sites.

6f5974606ad4564a69c37f634c22042d NCT00253747

Eugene Somoza, M.D., Ph.D
University of Cincinnati/Cin ARC
3210 Jefferson Avenue, Suite 6
Cincinnati, OH 45220
Somoza@carc.uc.edu

Theresa Winhusen, Ph.D.
Professor of Psychiatry and Behavioral Neuroscience, Director of Addiction Sciences Division
University of Cincinnati
Addiction Sciences Division
3131 Harvey Avenue, Suite 104
Cincinnati, OH 45229-3006
winhust@ucmail.uc.edu

Eugene Somoza, M.D., Ph.D

University of Cincinnati/Cin ARC

3210 Jefferson Avenue, Suite 6, Cincinnati, OH, 45220, US

Somoza@carc.uc.edu

T. John Winhusen, Ph.D.

Professor of Psychiatry and Behavioral Neuroscience, Director of Addiction Sciences Division

University of Cincinnati

3131 Harvey Avenue, Suite 104, Cincinnati, OH, 45229-3006, US

winhust@ucmail.uc.edu

CTN-0029 DSMB-0029

Participating Sites

completed